Delivery Order 36F79722D0178-W901UZ22F0064
Award Date 8/17/22
Potential Completion Date 9/14/22
Potential Value $35K
Funding Federal Agency
Contracting Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
PSC Category
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Research Triangle Park, NC 27709, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Department of the Army awarded a delivery order to GlaxoSmithKline LLC for the procurement of 210 boxes of Fluarix Trivalent influenza vaccine in 0.5ml syringes, with a ceiling value of $32,602.50. This firm fixed-price delivery order, issued on August 21, 2025, will be performed in Research Triangle Park, North Carolina, with an ultimate completion date of September 13, 2025. The contract was awarded under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) and carries no...
- The Department of Veterans Affairs Veterans Health Administration awarded Glaxosmithkline, LLC a $37,224 delivery order to supply 58160-0885-52 FLUARIX PRE-FILLED SINGLE DOSE SYRINGE-QUADRIVALENT under a firm fixed price contract. As the prime contractor, Glaxosmithkline will deliver the influenza vaccines to locations within Veterans Integrated Service Network 6, with performance taking place in Research Triangle Park, North Carolina over a one month period concluding in early May. The award...
- The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 20 awarded Glaxosmithkline, LLC a $0.00 firm fixed price delivery order for PHARMACY FLUARIX QUADRIVALENT with no set-aside designation. The delivery order was awarded on September 16, 2020 with a completion date of March 31, 2021. Glaxosmithkline will provide influenza vaccines under this contract to support the VA's efforts to provide healthcare services to veterans through its integrated...
- The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 6 awarded Glaxosmithkline, LLC a $192,324 delivery order to provide 58160-0885-52 Fluarix Quadrivalent influenza vaccine. As the prime contractor, Glaxosmithkline will deliver the requested vaccines from its Research Triangle Park, North Carolina facility under firm fixed pricing by May 8, 2020. The delivery order was issued against an existing VA pharmaceutical schedule to support VHA's efforts...
- This federal contract award, valued at $78,840.00, was issued by the Department of the Army to Glaxosmithkline, LLC, a pharmaceutical company, to provide individual doses of the flu vaccine. The contract is a delivery order under Glaxosmithkline's existing General Services Administration (GSA) Federal Supply Schedule (FSS) contract for Pharmaceuticals and Drugs. The contract has a firm fixed price pricing type and does not utilize any set-aside designations. Glaxosmithkline has a history of...
- The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 21 awarded a $165,984 delivery order contract to Glaxosmithkline, LLC for FLUARIX PRE-FILLED SINGLE DOSE vaccines. As the prime contractor, Glaxosmithkline will deliver the pre-filled influenza vaccines to locations in Research Triangle Park, North Carolina between April and October 2019. The firm fixed price contract supports VHA's efforts to provide preventative healthcare services to veterans...
- The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 21 awarded a $177,840 delivery order contract to Glaxosmithkline, LLC for FLUARIX PRE-FILLED SINGLE DOSE vaccines. As the prime contractor, Glaxosmithkline will deliver the pre-filled influenza vaccines to locations in Research Triangle Park, North Carolina between April and October 2019. The firm fixed price contract supports VHA's efforts to provide preventative healthcare services through...
- This is a delivery order contract awarded by the Department of Veterans Affairs Veterans Health Administration to Glaxosmithkline, LLC for the supply of FLUARIX R PRE-FILLED SINGLE DOSE SYRINGE -QUADRIVALENT influenza vaccine. The firm fixed price contract has a potential value of $121,400.50 and a completion date of April 30, 2018. The contract is not designated as a set-aside. Glaxosmithkline, a pharmaceutical company that provides vaccines and other medical products to U.S. government...
- This is a firm fixed price delivery order awarded by the Department of Veterans Affairs Veterans Health Administration to Glaxosmithkline, LLC, a foreign-owned, for-profit pharmaceutical company, for the supply of FLUARIX QUADRIVALENT 0.5ML PREFILLED TIP-LOK SYRINGE. The potential value of the contract is $210,936.00, and the contract did not have a set-aside designation. The contract was issued to support the VA's vaccine and immunization programs, with performance occurring at...
- The Department of Veterans Affairs Veterans Health Administration awarded a $102,366 delivery order to Glaxosmithkline, LLC for FLUARIX flu vaccine. The contract is being performed in Research Triangle Park, North Carolina under firm fixed pricing from April 9, 2020 through October 15, 2020. Glaxosmithkline will supply the flu vaccine to support VHA's Veterans Integrated Service Network 5, which coordinates and manages health care services for veterans in parts of North Carolina, South...
- Pharmaceuticals and Drugs (FSS-61-IB)Master GSA Schedule
- 36F79722D0178Federal Supply Schedule
- 36F79722D0178-W901UZ22F0064Delivery Order
The Department of the Army awarded a $34,586.40 firm fixed price delivery order to Glaxosmithkline, LLC for FLUARIX QUADRIVALENT FLU VACCINE. As the prime contractor, Glaxosmithkline will deliver the influenza vaccine to support the Department of the Army's public health and readiness programs. The contract has a period of performance through September 14, 2022 and was awarded on August 17, 2022 without a set-aside designation. The place of performance will be Glaxosmithkline's facility in Research Triangle Park, North Carolina.
Generated 1/3/24, 8:15 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $34.6k | 8/17/22 |